Nolan Priedigkeit

[MLB @MLB]

Jacob Misiorowski threw 10 pitches in the 1st inning:

102.4 MPH
103.0 MPH
102.8 MPH
102.7 MPH
103.2 MPH
103.3 MPH
103.3 MPH
103.5 MPH
103.1 MPH
103.6 MPH

[Christine A. Garcia, MD, MPH @christinemphmd]

New @Nature study: >50% of lung cancer metastases are seeded by other metastases, not the primary tumor. This "seeding from seeding" reveals a complex evolutionary cascade that allows cancer to colonize the body.
https://t.co/lYUyfRYOcP

[Dana-Farber News @DanaFarberNews]

Congratulations to @DanaFarber’s Alan D’Andrea, MD, and @judygarber5 on their election to the American Academy of Arts and Sciences.

➡️ https://t.co/EyNxFCTJKR

[Cancer Discovery @CD_AACR]

Now online: Spatial integration of protein and chromosomal states reveals early copy number changes and genotype-associated immune neighborhoods in serous ovarian cancer evolution https://t.co/WfF2BlcQTz

[nature @Nature]

Nature research paper: Prospective evaluation of genomics-guided off-label treatment

https://t.co/nQAqjSJBow

[Jorge Gómez Tejeda Zañudo @jgtzanudo]

Our BCCB group is at #AACR26!

Led by Diana Garcia, and working with @DrDAbravanel
and I, we present the multi-omics and evolutionary analysis of the MBCproject

Session: PO.MCB08.05
When: Wed April 22 2026, 9 AM - 12 PM
Poster 7265

https://t.co/zC33AzNZFN

@DFCI_BreastOnc

[Elvina Almuradova @Dr_ElvinaA]

Leptomeningeal disease may no longer be a “therapeutic dead end.”
TBCRC049 (phase II):
▪️ OS: 10 months (vs ~4–5 historical)
▪️ LM response: 38%
▪️ Neuro improvement: 58%

➡️ Tucatinib + trastuzumab + capecitabine shows real clinical activity

#bcsm #oncology #HER2
@NatureCancer @Larvol @OncoAlert @PTarantinoMD

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Congratulations to Jose Pablo Leone, MD on his promotion to Associate Professor of Medicine at Harvard Medical School!

[Dana-Farber IBC Program @IBC_DanaFarber]

Join us On April 11! Dr. Faina Nakhlis will talk about what happens in the OR, including Axillary Lymph Node Dissection, Modified Radical Mastectomy and Delayed Reconstruction as Standards of Care for IBC. Register Here: https://t.co/cQcqOfd2LF

[TIME @TIME]

TIME’s new cover: Artemis II is poised for the first lunar mission since 1972 https://t.co/FVr569aQR3

[Sara Tolaney @stolaney1]

Huge congratulations to @Otto_DFCI and the Alliance team!!!! Wonderful to see PATINA in @NEJM !!!!

@DFCI_BreastOnc

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

PATINA study in @nejm
Establishes 'maintenance' therapy as the standard after induction for 1st line HER2+ MBC.
Congrats to @Otto_DFCI @DFCI_BreastOnc for remarkable persistence and work. https://t.co/s0IwF8MFdl

[Sarah Yáñez-Richards @SarahYanezR]

It's snowing in New York

[Carmine Valenza @ValenzaCarmine]

In this multicenter cohort of pts with pN+ ER+ eBC who remained premenop after 5y of LHRHa, extended ET was associated with a clinically meaningful benefit

Thanks to all the coauthors!

@Harvard @HarvardChanSPH @harvardmed @IEOufficiale @LaStatale @DFCI_BreastOnc @DanaFarber

[Eric Topol @EricTopol]

Genome editing for treatment of diseases has been constrained to blood, liver and eye targets due to delivery obstacles. But that's about to change.
a @NatureBiotech review
https://t.co/NJHiMlHMVY

[Julie Gralow @jrgralow]

Hanging out at #GI26: @ASCO mtg mascots Liam the Llama & Marty the Merlion. Liam’s 1st mtg was #ASCOQLTY25 - he’s pretty impressed w/GI. Marty, official mascot of #ASCOBT26, is gearing up for Breakthrough in Singapore. A merlion -1/2 lion, 1/2 fish- is Singapore’s mythical mascot

[Yale Cancer Center @YaleCancer]

Congratulations to @AminNassarMD, named a recipient of an Emerging-Generation Award by @the_asci. E-Gen Awards recognize post-MD, pre–faculty appointment physician-scientists who are meaningfully engaged in immersive research.
@SmilowCancer @YaleHemOnc

[AACR @AACR]

Congratulations to Zachary A. Yochum, MD, PhD, recipient of the 2025 AACR-@ExelixisInc Renal Cell Carcinoma Research Fellowship. We look forward to his findings on ERV-specific T cells and their role in anti-tumor immunity and ICI response in renal cell carcinoma.

[Sara Tolaney @stolaney1]

Great to see T-DXd+P approved for 1L metastatic HER2+ breast cancer based on DB09!!

@OncoAlert @DFCI_BreastOnc

[Dr. E Mittendorf @EMittendorfMD]

It takes a team - new @ASCO guidelines on managing patients diagnosed with cancer while pregnant